Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer

Table 3 Pathological Staging after Surgery

Stage	Total 40 Patients
Complete Response	13 patients (32.5 %)
Microscopic Residual Disease	6 patients (15 %)
Stage I	3 patients (7.5 %)
Stage IIA	4 patients (10 %)
Stage IIB	4 patients (10 %)
Stage III	5 patients (12.5 %)
Stage IVA	3 patients (7.5 %)
Stage IVB or Refused Surgery	2 patients (5 %)

ISSN: 1471-2407